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Blastocystis is the most common eukaryotic microbe in the human gut. It is linked to
irritable bowel syndrome (IBS), but its role in disease has been contested considering its
widespread nature. This organism is well-adapted to its anoxic niche and lacks typical
eukaryotic features, such as a cytochrome-driven mitochondrial electron transport.
Although generally considered a strict or obligate anaerobe, its genome encodes an
alternative oxidase. Alternative oxidases are energetically wasteful enzymes as they are
non-protonmotive and energy is liberated in heat, but they are considered to be involved
in oxidative stress protective mechanisms. Our results demonstrate that the Blastocystis
cells themselves respire oxygen via this alternative oxidase thereby casting doubt on its
strict anaerobic nature. Inhibition experiments using alternative oxidase and Complex
II specific inhibitors clearly demonstrate their role in cellular respiration. We postulate
that the alternative oxidase in Blastocystis is used to buffer transient oxygen fluctuations
in the gut and that it likely is a common colonizer of the human gut and not causally
involved in IBS. Additionally the alternative oxidase could act as a protective mechanism
in a dysbiotic gut and thereby explain the absence of Blastocystis in established IBS
environments.
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INTRODUCTION
A healthy human gut is characterized by the presence of obligate anaerobic bacteria from the
Firmicutes and Bacteroides phyla who are considered to play a protective role in maintaining the
gut ecosystem (Donaldson et al., 2016). The establishment of this protective microbial ecosystem
in the gut has its origin within the first few days/weeks after birth and even the mode of birth
(cesarean or natural) can result in effects in later life (Sommer et al., 2017). The resilience of the
gut ecosystem, which co-evolved with humans, is illustrated by the fact that generally, the gut flora
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returns to its original state after perturbations, such as antibiotic
treatment or infections (Donaldson et al., 2016; Sommer et al.,
2017). However, certain perturbations can result in a detrimental
new equilibrium that is not beneficial to the human host. For
example, an increase in facultative anaerobic Enterobacteriaceae
is generally linked to a dysbiosis of the gut, where an increase in
the luminal bioavailability of oxygen causes a shift in intestinal
biodiversity (Rigottier-Gois, 2013; Byndloss et al., 2017; Rivera-
Chávez et al., 2017). Recently, a mechanistic coupling between
gutmicrobes and the presence ofmolecular oxygenwas described
by Byndloss et al. Activation of a colonocyte peroxisome
proliferator-activated receptor-γ (PPARγ) results in reduction
of the nitrate and oxygen concentrations in the gut thereby
controlling the proliferation of facultative anaerobes (Byndloss
et al., 2017). This clearly demonstrates a link between oxygen in
the human intestine and dysbiosis as previously hypothesized by
Rigottier-Gois (2013).
Intestinal dysbiosis has been linked to several diseases
including obesity and irritable bowel diseases, such as Crohn’s
disease and ulcerative colitis and to irritable bowel syndrome
(IBS) (Rigottier-Gois, 2013; Goulet, 2015). IBS is a common
gastrointestinal disease presenting with abdominal pain,
constipation, diarrhea and bloating (Enck et al., 2016). It is
now generally accepted that IBS is accompanied by a changed
microbial gut flora (Simrén et al., 2013) which seems adapted to
higher oxygen levels in the gut (Rigottier-Gois, 2013) based on
reported increases in Enterobacteriaceae in IBS patients (Carroll
et al., 2012). Although most studies focus on bacterial taxa in
IBS patients, some studies have assessed the contribution of
microbial eukaryotes (Engsbro et al., 2012; Nourrisson et al.,
2014; Krogsgaard et al., 2015; Nash et al., 2017). Specifically,
Blastocystis is frequently associated with IBS, however its role
in disease is contested (Clark et al., 2013; Ajjampur and Tan,
2016; Gentekaki et al., 2017; Stensvold and van der Giezen,
2018). Although it is the most common microbial eukaryote of
the human gut, which can reach a prevalence of up to 100% (El
Safadi et al., 2014), little is known about its virulence (Ajjampur
and Tan, 2016; Ajjampur et al., 2016). This limited amount of
information is compounded by the massive genetic diversity
observed between isolates (Stensvold et al., 2007; Ajjampur
and Tan, 2016; Gentekaki et al., 2017). Currently, Blastocystis is
considered to be a strict anaerobe (Zierdt, 1986), which makes its
role in the IBS gut even more confusing, especially considering
the conflicting reports linking it to IBS (Nourrisson et al.,
2014; Krogsgaard et al., 2015). Blastocystis received additional
attention due to its unusual mitochondrion (Lantsman et al.,
2008; Stechmann et al., 2008; Müller et al., 2012; Gentekaki et al.,
2017). As an anaerobe, and similar to other anaerobic microbial
eukaryotes, it has lost many classic features of mitochondria and
performs no oxidative phosphorylation and lacks a standard
mitochondrial electron transport chain (see for example van
der Giezen, 2011). It has retained Complex I which supposedly
Abbreviations: AOX, alternative oxidase; DDT, dichloro diphenyl
trichloroethane; EST, expressed sequence tag; IBS, irritable bowel syndrome;
ROS, reactive oxygen species; SHAM, salicylhydroxamic acid; TAO, trypanosomal
alternative oxidase; TTFA, Thenoyltrifluoroacetone
maintains a proton motive force across the inner membrane
and passes electrons via rhodoquinone to a fumarate reductase
(Stechmann et al., 2008) which acts as an alternative Complex
II (Tielens et al., 2002; Müller et al., 2012). It has also retained
a mitochondrial genome (Pérez-Brocal and Clark, 2008). In
addition to the canonical mitochondrial iron-sulfur cluster
assembly system Blastocystis also has a prokaryotic SUF system
that was localized in its cytosol (Tsaousis et al., 2012). Recently,
it was also shown that Blastocystis contains part of glycolysis in
its mitochondrion (Bártulos et al., 2018). Although Blastocystis
can produce some ATP via substrate level phosphorylation using
the TCA cycle enzyme succinyl-CoA synthetase (Hamblin et al.,
2008) it is mainly reliant on fermentation producing lactate,
acetate and probably propionate (Stechmann et al., 2008; Müller
et al., 2012). The Blastocystis mitochondrion is predicted to
contain an alternative oxidase which “should” accept electrons
from Complex I and II (Stechmann et al., 2008; Standley and van
der Giezen, 2012). Alternative oxidases are non-protonmotive
quinol–oxygen oxidoreductases which couple the oxidation
of ubiquinol to the 4-electron reduction of molecular oxygen
to water (Moore and Albury, 2008). These enzymes are found
in several non-related organisms. Their physiological role is
not completely clear but it has been suggested to be involved
in oxidative stress protective mechanisms, heat generation
and to maintain tricarboxylic acid cycle turnover under high
cytosolic phosphorylation potential (Moore and Albury, 2008).
Alternative oxidases have been found in other parasites, such as
Cryptosporidium (Roberts et al., 2004) and trypanosomes (Nihei
et al., 2002). The trypanosome homolog is well-studied as it is
considered a potential drug target due to its absence in humans
(Shiba et al., 2013).
Here, we report the biochemical characterization of
an alternative oxidase in Blastocystis and relate this to
the organism’s ability to cope with fluctuating oxygen
concentrations in the gut and its postulated role in
disease.
MATERIALS AND METHODS
Organisms and Culture Conditions
Blastocystis strain NandII cDNA was obtained from the
Blastocystis hominis EST project (Stechmann et al., 2008). Human
Blastocystis sp. isolate DMP/02-328 was obtained during routine
screening and was grown at 36◦C with a mixed bacterial flora
in LYSGM with 5% adult bovine serum. Cells were grown
under anoxic conditions and all culturing work performed in
an anaerobic chamber (Ruskinn SCI-tive with HEPA Hypoxia
station). LYSGM is a modification of TYSGM-9 in which the
trypticase and yeast extract of the latter are replaced with 0.25%
yeast extract (Sigma) and 0.05% neutralized liver digest (Oxoid).
Subtyping of Blastocystis sp. DMP/02–328 indicated that this
strain is subtype 4 (Stensvold et al., 2007) whereas Blastocystis sp.
NandII is subtype 1.
Escherichia coli strain α select silver efficiency (Bioline) was
used for cloning and heme deficient E. coli strain FN102 (1hemA
(KmR)) (Nihei et al., 2003) was used for recombinant Blastocystis
AOX expression.
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AOX Cloning, Expression and Purification
The putative AOX gene was originally identified in the
Blastocystis hominis EST project (http://amoebidia.bcm.
umontreal.ca/pepdb) using BLASTn with the ESTs as queries.
Full-length genes were obtained by 5′ and 3′ rapid amplification
of cDNA ends using the GeneRacer Kit (Invitrogen). AOX
sequences from Blastocystis, Sauromatum guttatum, and
Trypanosoma brucei were aligned using ClustalW (Chenna et al.,
2003) and examined.
BlastocystisAOXwas amplified from cDNA using the forward
primer 5′-aga aga CAT ATG TTC CCT ATC CTC TCC AGA
GTC TTC-3′ and the reverse primer 5′-tct tct GGA TCC TTA
CGC TTT CGT TGC GCC GTA CTT CG-3′ which added NotI
and BamHI restriction sites (indicated in italics), respectively.
Amplification was carried out with Phusion High-Fidelity DNA
polymerase (New England Biolabs) yielding amplicons of the
expected size (∼0.9 kb). PCR products were purified using
QIAquick Gel Extraction Kit (QIAGEN), digested with BamHI
and NotI restriction digestion enzymes and cloned into pET-14b
(Novagen). The pET-14b vector added a 6XHis tag to the N-
terminus of AOX. The AOX pET-14b plasmid was purified using
QIAprep SpinMiniprep Kit (QIAGEN), sequenced to confirm its
validity (MWG) and used to transform FN102 E. coli cells.
FN102 membrane purification was carried out as described
by Nihei et al. (2003) with minor modifications. Briefly,
starter cultures of K broth with ampicillin, kanamycin and
aminolevulinic acid (ALA) were inoculated and incubated at
37◦C until they reached an OD600 of 0.1. Starter cultures were
added to large scale cultures of K broth with carbenicillin until
they reached an OD600 of 0.01. Large-scale cultures were grown
at 30◦C until they reached OD600 of 0.1, induced with 100µM
IPTG and incubated for 8 h at 30◦C. Cells were harvested by
centrifugation at 3,500 g for 20min at 4◦C. Harvested cells were
resuspended in 30ml of Buffer S (60mM Tris-HCl pH 7.5, 5mM
DTT, 300mM NaCl, 20% sucrose). Cells were broken with a
sonicator and centrifuged twice at 4,000 g for 10min at 4◦C to
pellet cell debris. The supernatant was layered on top of buffer
G (60mM Tris-HCl pH 7.5, 5mM DTT, 300mM NaCl, 40%
sucrose) to create a sucrose gradient and centrifuged at 200,000 g
for 1 h at 4◦C. Pelleted membranes were resuspended in ∼0.5ml
of buffer S.
AOX Assay
AOX activity was determined polarographically following uptake
of oxygen using a Clark-type electrode (Rank Brothers,
Cambridge, U.K.) using 0.1–0.5mg E. colimembranes suspended
in 0.4ml air-saturated reaction medium (250µM at 25◦C)
containing 50mM Tris–HCl (pH 7.5). Data were recorded
digitally using a PowerLab/4SP system (ADInstruments Pty, UK)
with Chart version 3.6s software (ADInstruments).
Western Blotting
Blastocystis whole-cell protein lysate, from strain DMP/02-
328, was separated on a 10% sodium dodecyl sulfate (SDS)
polyacrylamide gel and blotted on to nitrocellulose membrane
(Bio-Rad). Anti-Sauromatum guttatum AOX (1:1,000) was
used as primary antibody followed by anti-mouse HRP
conjugate (Pierce) 1:10,000 as a secondary antibody. Signal
was detected using a CN/DAB Substrate Kit (Pierce). Different
cell fractions were isolated following procedures previously
described (Tsaousis et al., 2014). Blastocystis cells from NandII
strain (well-grown in media for 5 days) were harvested by
centrifugation at 1,200 × g for 10min at 4◦C. Cells were
resuspended in Locke’s solution (pH 7.4) and pelleted again
at the same speed for the same duration. Cells were then
broken with 40 strokes in a 10-ml Potter-Elvehjem tissue
homogenizer at 4◦C in isotonic buffer (200mM sucrose, pH
7.2, 30mM phosphate, 15mM β-mercaptoethanol, 30mM NaCl,
0.6mM CaCl2, 0.6mM KCl). Broken cells were diluted with
isotonic buffer and then centrifuged at 700 × g for 10min
using a Sorvall RC-2B centrifuge to remove unbroken cells.
The supernatant was collected and centrifuged at 5,000 × g
for 20min to pellet the large granular fraction (LGF), where
MROs are found (see Lantsman et al., 2008; Tsaousis et al.,
2014; Bártulos et al., 2018). The LGF was resuspended (washed)
in isotonic buffer and pelleted as described above. Finally, all
fractions were stored at −20◦C in NuPAGE LDS sample buffer
along with 10× sample reducing agent (Invitrogen). Depending
on the amount of protein, 5 to 20 µl of the supernatant was
analyzed using a polyacrylamide mini gel and subsequently
blotted as above. Cellular fractions were analyzed using anti-
Blastocystis hydrogenase (Stechmann et al., 2008) (1:250) and
anti-Blastocystis SufCB (Tsaousis et al., 2012) (1:500) antisera,
as controls for the mitochondrial organelle and cytoplasm,
respectively. A loading control is shown in Figure 3B.
Immunolocalization of AOX
Blastocystis cells were resuspended in 1 X phosphate buffered
saline (PBS) pH 7.4 and were transferred to pretreated poly-L-
lysine slides (Sigma). Slides were incubated at 4◦C for 2 h and
then washed for 5min in 1X PBS. The cells on the slides were
fixed with 3.7% formaldehyde/0.5% acetic acid for 15min at
37◦C. Slides were washed for 5min in PBS/0.5% Tween-20 and
then permeabilized with 0.1% Triton X-100 for 5min. Washes
were performed three times for 5min in PBS/0.05% Triton X-100
for 5min. Fixed cells were incubated for 30min with a blocking
solution of 5% skimmed milk powder in 1X PBS solution (w/v)
and then rinsed with 0.5% milk/PBS solution for 30min. The
cells were then incubated with an anti-S. guttatumAOX antibody
(1:100 dilution) in 1% milk/PBS solution overnight at 4◦C. After
three rinses in 1% milk/PBS for 10min, the slides were incubated
with a fluorescent dye-labeled (Alexa 488 green) goat secondary
antibody at a dilution of 1:200. For colocalization experiments,
before fixation, cells were incubated for 20min with 200 nm
of MitoTracker Red CMXRos (Molecular Probes). Cover slips
were mounted with anti-fade mounting medium (Vectashield)
and observed under an Olympus IX81 fluorescence microscope.
Images were collected using Micromanager 1.4 software and
processed with ImageJ.
High-Resolution Respirometry
Oxygen consumption was measured in E. coli control or AOX
expressing cells using a high-resolution respirometer (Oxygraph-
2k; Oroboros) calibrated to 37◦C in LB media and data
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recorded using DatLab software. Changes in the rate of oxygen
consumption were measured following repeated additions of
salicylhydroxamic acid (SHAM) to give a final concentrations of
1.2, 3.6, 7.0 and 9.4mM or the appropriate volume of the carrier
solvent (ethanol) as a control.
Cultured Blastocystis cells were collected anaerobically and
gently pelleted at 800 × g for 10min and re-suspended in sterile
anoxic Locke’s solution to a cell density of 1 × 106 cells/ml. The
oxygen consumption rate was measured using a high-resolution
respirometer (Oxygraph-2k; Oroboros) calibrated to 28◦C and
data were recorded at 1 s intervals using DatLab software. The
effects on oxygen consumption following addition of the AOX
inhibitor, SHAM (Sigma), at 2.4 or 4.8mM, or the succinate
dehydrogenase inhibitor, TTFA (Sigma), at 5.4 or 11µM as
indicated. Ethanol was used as the solvent for both SHAM and
TTFA whilst DMSO was used for antimycin A (1µM) (Sigma)
and octylgallate (OG) (11µM) (Sigma).
Protein Modeling
Blastocystis AOX was modeled to the TAO crystal structure
(PDB:5GN2) using the Swiss-model software (http://swissmodel.
expasy.org/; Arnold et al., 2006; Benkert et al., 2011; Biasini
et al., 2014). The protein structure of Blastocystis AOX was
loaded into MOE software (Molecular Operating Environment,
version 2016.08, Chemical Computing Group Inc., Montreal,
Canada) for some preparatory steps to correct any structural
issues. Hence, the QuickPrep panel was used to optimize the
hydrogen bond network using the Protonate 3D algorithm and
to perform an energy minimization on the system. AMBER99
forcefield was used in assigning correct electronic charges and
protonation of amino acid residues. The 3D structure for
rhodoquinol was built within MOE and energy minimized
using the Amber10:EHT forcefield. A second minimization was
applied using the MOPAC semi-empirical energy functions
(PM3 Hamiltonian). Rhodoquinol was docked into the binding
site of the AOX using the Triangle Matcher placement
method with London dG scoring. Subsequently, poses resulting
from the placement stage were further refined using the
Induced Fit method, which allows protein flexibility upon
ligand binding, improving the prediction accuracy for the
interaction. Poses were then rescored using the GBVI/WSA
dG scoring function and the top five best scoring poses were
retained.
RESULTS
AOX Primary Sequence Analysis
The AOX EST cluster originally identified in the Blastocystis
NandII strain EST data (Stechmann et al., 2008) appeared to
be chimeric with a 40S ribosomal protein. Rapid amplification
of cDNA ends (RACE) allowed the full 5′ and 3′ ends of
the AOX gene to be obtained. The obtained sequence is
identical to the one found in the recently completed Blastocystis
sp. NandII genome (Gentekaki et al., 2017). The Blastocystis
AOX gene encodes for a 304 amino acid protein with a
predicted molecular weight of 35 kDa. The Blastocystis AOX
sequence has been deposited into GenBank (accession number:
FJ647192).
Blastocystis NandII, Sauromatum guttatum and Trypanosoma
brucei AOX sequences were aligned to determine if residues
known to be important for catalysis in other species were
present in the Blastocystis homolog. The alignment shown
in Figure 1 clearly demonstrates that many of the conserved
features associated with AOX are present in the Blastocystis
sequence. A surface model of the Blastocystis AOX, using the
trypanosomal alternative oxidase (TAO) crystal structure as a
template, is depicted in Figure 2A. The orange coloring indicates
the hydrophobic surface and the membrane face depicted in
Figure 2A is the surface which interacts with the mitochondrial
inner membrane. Figure 2A also shows the hydrophobic cavity
leading to the di-iron center. The residues lining the active
site, which coordinate the diiron center (namely the 1◦ ligation
sphere; T. brucei numbering throughout: E123, E162, E213,
E266, H165 and H269), are all conserved (Shiba et al., 2013;
Figure 2B). In addition, Figure 2B also illustrates that residues
involved in the 2◦ ligation sphere (N161, Y220, D265, Y246,
FIGURE 1 | Functional residues are conserved in the Blastocystis alternative oxidase (AOX). The Blastocystis AOX was aligned to the Trypanosoma brucei and
Sauromatum guttatum AOX sequences. Residues involved in coordinating the diiron in the active site are indicated in brown. Quinone binding residues are indicated
by an orange background and possible rhodoquinol coordinating residues are indicated by a yellow background. The S. guttatum T179 postulated in oxygen affinity
has been indicated by a yellow background and an orange rim. The epitope recognized by the S. guttatum AOX monoclonal antibody is indicated by a brown box.
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FIGURE 2 | Blastocystis alternative oxidase (AOX) homology modeling from the trypanosomal alternative oxidase (TAO) crystal structure (PDB:5GN2) generated using
the Swiss-model software (http://swissmodel.expasy.org/). (A) Surface representation of the model, with hydrophobic residues colored orange. (B) Primary and
secondary ligation sphere, with numbering based on the TAO amino acid numbering. Non-conserved amino acids are labeled in parenthesise. (C,D) Show the same
docked rhodoquinol (magenta) from two different orientations. Amino acids shown as sticks are all within 6 Å of the substrate, with potential hydrogen bonds to
(E215H) (T219S) and the iron core shown as yellow dotted lines. Atoms are colored as yellow for carbon, blue for nitrogen and red for oxygen, with the iron core as
orange spheres.
and W247), which function in electron transport and the oxygen
reduction cycle are also conserved in the Blastocystis sequence
(Affourtit et al., 2002; Moore and Albury, 2008; Young et al.,
2016).
Interestingly, however, several of the residues involved in
substrate and inhibitor-binding are different in Blastocystis
compared to T. brucei. Although the majority of these residues
are conserved (such as R118, L122, E123, A216, E162, H165,
L212, E213, A216 and E266), several residues shown to interact
with the tail of both substrate and inhibitors in T. brucei have
been modified (as depicted in Figure 2B: R96F, D100N, and
T219S). Since Blastocystis is an anaerobe it seems unlikely that it
utilizes ubiquinone as substrate but probably uses rhodoquinol
instead (Stairs et al., 2018) which operates at a much lower
midpoint potential.
In order to assess the influence of these substitutions
upon substrate binding, docking studies of rhodoquinol
were undertaken using the homology model described in
FIGURE 3 | The Blastocystis alternative oxidase (AOX) is enriched in
mitochondrial fractions. (A) Western blot analyses of the expression and
cellular localization of Blastocystis AOX, the Blastocystis mitochondrial marker
hydrogenase and cytosolic marker SufCB. (B) Typical SDS-PAGE gel of
protein extracts from whole cells, mitochondrial and cytosolic fractions of
Blastocystis stained with Coomassie blue.
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Figures 2C,D. As shown in Figure 2C, rhodoquinol is bound
in a fashion analogous to the position determined for ubiquinol
within the TAO crystal structure (Shiba et al., 2013), with the
binding positions for 1-OH and 4-OH positioned between
the iron core and T219S, respectively. What is apparent from
Figures 2C,D is that the proposed proton transfer network
within TAO (involving R96, D100, and E215; Young et al., 2016)
is completely missing, and appears to have been replaced instead
by a single histidine. Given the proximity of this histidine to the
proposed rhodoquinol binding site, ∼2.9 Å from the OH, and
the likelihood it has free rotation around the R-group due to lack
of a secondary binding point, it is highly likely that the histidine
is able to act as a pathway for proton removal to solvent, thereby
fulfilling a similar role within the quinol reactivity mechanism as
the previously described pathway (Young et al., 2016).
As rhodoquinol is subtly different from ubiquinone, the
residues which are different from T. brucei TAO might
actually coordinate the rhodoquinol in the Blastocystis AOX.
In agreement with this assertion is the discovery of RquA on
the Blastocystis genome (Gentekaki et al., 2017; Stairs et al.,
2018), a gene thought to encode an enzyme of the rhodoquinone
biosynthetic pathway (Lonjers et al., 2012; Stairs et al., 2018).
Similar to other parasites including microsporidia, Blastocystis
does not contain any of the cysteine residues which, in plants at
least, are thought to be involved in AOX activation by pyruvate
(Rhoads et al., 1998). Its absence in Blastocystis suggests that this
organism, similar to the microsporidian and the trypanosomal
AOX, is not regulated by α-keto acids. In addition, T124 which
has been linked to changes in oxygen affinity (Moore and Albury,
2008) has been changed to a serine residue in Blastocystis.
Blastocystis AOX Protein Is Mitochondrial
Comparing the Blastocystis AOX sequence with the Sauromatum
guttatumAOX indicates that the epitope for the S. guttatumAOX
monoclonal antibody (RADEAHHRDVNH) is quite conserved
in Blastocystis NandII. Of the twelve residues, ten are identical
(see Figure 1). We therefore decided to test the S. guttatum
antibody on Blastocystis NandII total protein extracts. Western
blotting of Blastocystis fractions detected a single protein, which
is enriched in the mitochondrial fraction, of ∼29 kDa, in
reasonable agreement with the predictedmolecular weight for the
Blastocystis AOX (Supplementary Figure 1A). Targeting signal
predictions, such as Mitoprot (Claros and Vincens, 1996) and
pSORT (Horton et al., 2007) failed to predict a mitochondrial
targeting signal which could have explained the size difference
between the observed and calculated molecular weight of the
Blastocystis AOX. Amino acid composition and globularity of
a protein do play a role in the actual observed molecular
weight and membrane proteins are known the have issues in
this regard (Rath et al., 2009). Using the anti-AOX antibody
on Blastocystis cellular fractions clearly indicated an enrichment
in mitochondria (Figure 3A). The AOX band appeared in the
mitochondrial fraction, but absent in the cytosolic fraction,
consistent with the absence of this protein in Blastocystis
MROs. The anti-Blastocystis hydrogenase antiserum shows
specific detection of Blastocystis hydrogenase (Stechmann et al.,
2008) in the MRO fraction (MRO positive control) while the
anti-Blastocystis SufCB antiserum shows specific detection of
Blastocystis SufCB (Tsaousis et al., 2014) in the cytosolic fraction
(positive control for cytosolic fraction).
The S. guttatum AOX monoclonal antibody was subsequently
used to localize the AOX within Blastocystis cells using
immunofluorescence microscopy. The AOX antibody signal was
found to co-localize withMitoTracker Red CMXRos (Figure 4), a
mitochondrion-specific stain which has been used previously on
Blastocystismitochondria (Stechmann et al., 2008; Tsaousis et al.,
2009, 2012). It also co-localized with the mitochondrial DAPI
label in agreement with the presence of an organellar genome
(Nasirudeen and Tan, 2004; Pérez-Brocal and Clark, 2008). This
clearly suggests that AOX localized to the mitochondrion-related
organelle found in Blastocystis.
Blastocystis AOX Complements Heme
Deficient E. coli
To assay AOX activity, the Blastocystis AOX gene was expressed
in a heme deficient Escherichia coli strain [FN102 (1hemA
(KmR)) (Nihei et al., 2003)], where the gene for glutamyl-
tRNA reductase, the first enzyme in heme biosynthesis, has
been replaced with a kanamycin resistance gene. Expressing
AOX in this strain complements for the heme deficiency as it
provides E. coli with an additional terminal oxidase which does
not require heme for activity (Fukai et al., 2003). Therefore,
FIGURE 4 | The Blastocystis alternative oxidase (AOX) is localized in the mitochondrion. Several Blastocystis cells are shown. (A) Anti-AOX antibody recognizes
several discrete locations in Blastocystis. (B) Staining of the mitochondrion-like organelles with MitoTracker. (C) DAPI staining of DNA in the mitochondria and in the
nucleus. (D) Overlay of anti-AOX and Mitotracker demonstrating the co-localization of signal. (E) Merged of all signals with co-localization of anti-AOX, Mitotracker and
DAPI in the mitochondria and DAPI alone for the Blastocystis nuclei. (F) DIC image of the Blastocystis cells. Bar is 5µm.
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heme deficient cells expressing recombinant AOX do not
require the addition of aminolevulinic acid, a heme precursor,
which heme deficient cells normally require for aerobic growth
(Fukai et al., 2003). In addition, expressing AOX in a heme
deficient mutant reduces the potential for confusing AOX
activity with the activity of other quinol oxidases. The main
oxidases in E. coli use heme prosthetic groups for activity.
E. coli FN102 cells capable of growth without aminolevulinic
acid were further analyzed for the presence the Blastocystis
AOX. This protein could indeed be detected in a purified
membrane fraction from the heme deficient E. coli FN102 strain
(Supplementary Figures 1B, 2).
Blastocystis AOX Uses Oxygen and
Duroquinol and Is Sensitive to Octyl Gallate
The activity of AOX can be measured by oxygen uptake
with quinols as substrates. Figure 5A shows the results of
measuring oxygen uptake in the purified membranes of heme
deficient E. coli expressing recombinant Blastocystis AOX.
Addition of duroquinol (Sigma), an AOX substrate, initiates
oxygen consumption indicating that oxygen uptake only occurs
in the presence of quinols. Oxygen consumption is almost
completely abated by the addition of octylgallate, an AOX
inhibitor, clearly indicating that the oxygen consumption was
due to the activity of an AOX. To demonstrate that the
Blastocystis AOX is also sensitive to salicylhydroxamic acid
(SHAM), another AOX inhibitor, we measured the oxygen
consumption rate of the heme deficient E. coli FN102 strain
expressing the Blastocystis AOX in whole cells. Similarly, oxygen
consumption was affected by the AOX inhibitor (Figure 5B).
Together, this data suggests that the Blastocystis AOX consumes
oxygen in the presence of quinols and is sensitive to typical AOX
inhibitors.
Blastocystis Cells Respire Molecular
Oxygen
In order to assess whether Blastocystis cells themselves are
able to use molecular oxygen in vivo, whole Blastocystis cells
were analyzed in a high-resolution respirometer. The oxygen
consumption rate was measured in washed Blastocystis NandII
cells at a density of 1× 106 cells/ml at 28◦C. Live Blastocystis cells
consumed oxygen and this activity was affected by addition of
SHAM (Figure 6A). As AOX receives its electrons fromComplex
II (succinate dehydrogenase/fumarate reductase), we tested
the effect of the Complex II inhibitor thenoyltrifluoroacetone
(TTFA) on Blastocystis oxygen consumption. Similar to SHAM,
exposure to TTFA also affects the oxygen consumption rate of
Blastocystis in vivo (Figure 6B) suggesting the Blastocystis AOX
does indeed receive its reducing equivalents via Complex II (see
Supplementary Figure 3 for controls).
DISCUSSION
Blastocystis is the most common eukaryotic inhabitant of the
human gut (Gentekaki et al., 2017). It has been marred by
confusion almost from its first discovery in the nineteenth
century when it was linked to cholera (see Zierdt, 1991). It
has since then been associated with almost every eukaryotic
domain until it was clearly shown to be a member of the
large stramenopile lineage (Silberman et al., 1996). Stramenopiles
are an extremely diverse grouping and can be found in
many environments. It includes major plant pathogens, such
as Phytophthora, but also diatoms which are major primary
producers in the world’s oceans. Together with Pythium (Hilton
et al., 2016), Blastocystis is thought to be the only human
pathogen in this eukaryotic lineage. However, reports about
its supposed pathogenicity or role in disease are conflicting
FIGURE 5 | Oxygen uptake by Blastocystis alternative oxidase (AOX) in Escherichia coli. (A) Oxygen levels were allowed to stabilize before addition of heme deficient
E. coli membranes expressing recombinant Blastocystis AOX. Addition of duroquinol (DQH2) (final concentration of 1mM) induced oxygen consumption. Oxygen
uptake was sensitive to a typical AOX inhibitor octylgallate (OG). Octylgallate was added to a final concentration of 25µM. Oxygen consumption was not due to the
action of complex IV as protein was expressed in heme deficient E. coli and functional complex IV cannot be produced by these cells. Furthermore, antimycin A, a
complex III inhibitor, was added (AA) to a final concentration of 1µM. Rates shown on the graph are nmols O2 consumed/min/mg protein. (B) Oxygen consumption
by whole E. coli FN102 cells expressing Blastocystis AOX (orange trace) was measured using a high-resolution respirometer compared to E. coli cells not expressing
the Blastocystis AOX (brown trace). Oxygen consumption is roughly three times higher in the AOX expressing strain and sensitive to the AOX inhibitor
salicylhydroxamic acid (SHAM). Three independent experiments were conducted and a representative data set is presented.
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FIGURE 6 | The Blastocystis alternative oxidase (AOX) is sensitive to salicylhydroxamic acid and thenoyltrifluoroacetone. (A) Routine respiration was determined in
Blastocystis cells diluted to a density of 1 × 106 cells/ml before the addition of the AOX inhibitor salicylhydroxamic acid (SHAM) in two sequential 2.4mM doses.
Following SHAM addition the succinate dehydrogenase (Complex II) inhibitor thenoyltrifluoroacetone (TTFA) was added to a final concentration of 5.4µM. Shown are
an average of four independent experiments. Error bars represent standard deviation. (B) Routine respiration was determined in Blastocystis cells diluted to a density
of 1 × 106 cells/ml before the addition of two doses of the Complex II inhibitor TTFA was added to a final concentration of 5.4 and 11µM. Following this the AOX
inhibitor SHAM was added in two doses to a final concentration of 2.4 and 4.8mM. Shown are an average of two independent experiments. Error bars represent
standard deviation.
(see for example Miller and Minshew, 1988; Clark et al., 2013;
Stensvold and van der Giezen, 2018). Presence of Blastocystis
in stool samples of patients with gastrointestinal complaints
has repeatedly been reported. However, as it a faecally-orally
transmitted organism, people with Blastocystis in their intestines
might also have been exposed to other potential pathogens and a
causative relationship between disease and Blastocystis has never
been demonstrated.
In the literature, Blastocystis is often associated with irritable
bowel syndrome (IBS) although here again, the literature
is conflicting. Several cohort studies suggest a link between
Blastocystis and IBS (Yakoob et al., 2010; Jimenez-Gonzalez et al.,
2012; Nourrisson et al., 2014) while others do not (Petersen
et al., 2013; Krogsgaard et al., 2015; Beghini et al., 2017). A
possible explanation for these disparate findings is the large
genetic diversity observed within Blastocystis (Gentekaki et al.,
2017) where some subtypes might indeed be linked to disease
while others might not (Stensvold et al., 2007).
A factor that has thus far been overlooked in this respect is
the fact that Blastocystis is considered to be a strict anaerobe
(Zierdt, 1986) as it is incapable of oxidative phosphorylation
(Fenchel and Finlay, 1995). Genomic studies confirm the notion
that Blastocystis is indeed incapable of oxidative phosphorylation
as the classic cytochrome c oxidase (Complex IV) is absent
from its genome (Denoeud et al., 2011; Gentekaki et al.,
2017). Indeed, only Complex I and II are present suggesting
an anaerobic energy metabolism (Müller et al., 2012). The
presence of an alternative oxidase in Blastocystis is therefore
somewhat surprising as it suggests its energy metabolism might
not be completely independent of molecular oxygen. Alternative
oxidases are generally considered to be energetically wasteful
enzymes as they normally short-circuit the mitochondrial
electron transport chain by shuttling reducing equivalents from
Complex I or II away from the proton translocating respiratory
pathway to molecular oxygen without pumping protons across
the mitochondrial inner membrane (Shiba et al., 2013; May
et al., 2017). In plants AOX acts as a redox sink under stress
conditions, such as through respiratory inhibition or drought
thereby reducing the formation of deleterious reactive oxygen
species (ROS) production.
It is interesting to speculate as to whether it plays a similar
role in Blastocystis by not only providing a route of electron
transport from Complex I and II, and in doing so generate
a protonmotive force via Complex I, but also reduce ROS
production at Complex I and through reversed electron transport
from Complex II. Obviously, further experiments are required
to substantiate such a notion. Nevertheless, the result that the
Complex II inhibitor thenoyltrifluoroacetone inhibits alternative
oxidase function in whole Blastocystis cells suggests that the
alternative oxidase operates indeed via Complex II as in other
organisms (Stechmann et al., 2008).
The oxygen concentration in a healthy gut is extremely
low (Albenberg et al., 2014) to support growth of obligate
anaerobic bacteria from the Firmicutes and Bacteroides phyla.
These bacteria are important in maintaining a healthy gut
ecosystem (Donaldson et al., 2016). When the microbial flora in
the gut gets disturbed as in a dysbiotic gut, facultative anaerobic
Enterobacteriaceae establish themselves resulting in an increase
of the oxygen concentration (Rigottier-Gois, 2013; Byndloss et al.,
2017; Rivera-Chávez et al., 2017). This suggests that for a strict
anaerobe, such as Blastocystis, a dysbiotic gut is not the most ideal
ecosystem and that similarly to obligate anaerobic bacteria, it no
longer can maintain itself in this niche. Our data suggests that its
alternative oxidase might allow it to deal with fluctuating oxygen
concentrations that it might encounter in the gut. Similarly, it
was previously shown that Blastocystis also has other mechanisms
to deal with such oxygen fluctuations. In addition to the
standard eukaryotic mitochondrial oxygen-sensitive iron-sulfur
cluster assembly system, Blastocystis contains a SufCB protein
that is expressed under oxygen-stressed conditions (Tsaousis
et al., 2012). This might explain why some studies do not find
Blastocystis in IBS patients (Petersen et al., 2013; Krogsgaard
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et al., 2015; Beghini et al., 2017) and others do (Yakoob et al.,
2010; Jimenez-Gonzalez et al., 2012; Nourrisson et al., 2014).
In well-established IBS guts, the dysbiosis might have driven
Blastocystis out of the gut while in early stages of disease, the
normal gut colonizer might attempt to stay by means of utilizing
its alternative oxidase to protect itself from molecular oxygen
as has been suggested earlier (Gomes et al., 2001; Stensvold and
van der Giezen, 2018). Overall, our data suggests that Blastocystis
can cope with fluctuating oxygen concentrations that it might
encounter in the human gut and might be better described
as a microaerophile. However, considering its overall oxygen-
independent energy metabolism (Müller et al., 2012; Gentekaki
et al., 2017), it seems unlikely that the dysbiotic gut of IBS patients
is a suitable habitat for this anaerobe.
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